Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
36.36
-0.26 (-0.71%)
At close: Sep 4, 2026, 4:00 PM EDT
37.19
+0.83 (2.28%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Teva Pharmaceutical Market Cap
Teva Pharmaceutical has a market cap or net worth of $42.37 billion as of September 4, 2026. Its market cap has increased by 96.88% in one year.
Market Cap
42.37B
Enterprise Value
55.61B
1-Year Change
96.88%
Ranking
Category
Stock Price
$36.36
ChartMarket Cap Chart
Since December 1, 1998, Teva Pharmaceutical's market cap has increased from $6.10B to $42.37B, an increase of 594.38%. That is a compound annual growth rate of 7.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 42.37B | 18.33% |
| Dec 31, 2025 | 35.81B | 43.39% |
| Dec 31, 2024 | 24.97B | 113.39% |
| Dec 29, 2023 | 11.70B | 15.54% |
| Dec 30, 2022 | 10.13B | 14.65% |
| Dec 31, 2021 | 8.84B | -16.46% |
| Dec 31, 2020 | 10.58B | -1.18% |
| Dec 31, 2019 | 10.70B | -31.87% |
| Dec 31, 2018 | 15.71B | -18.33% |
| Dec 29, 2017 | 19.23B | -41.54% |
| Dec 30, 2016 | 32.90B | -41.16% |
| Dec 31, 2015 | 55.92B | 2.69% |
| Dec 31, 2014 | 54.45B | 43.98% |
| Dec 31, 2013 | 37.82B | 7.52% |
| Dec 31, 2012 | 35.17B | -7.04% |
| Dec 30, 2011 | 37.84B | -21.40% |
| Dec 31, 2010 | 48.14B | -3.59% |
| Dec 31, 2009 | 49.93B | 45.08% |
| Dec 31, 2008 | 34.41B | -6.66% |
| Dec 31, 2007 | 36.87B | 83.46% |
| Dec 29, 2006 | 20.10B | -25.46% |
| Dec 30, 2005 | 26.96B | 62.59% |
| Dec 31, 2004 | 16.58B | 13.05% |
| Dec 31, 2003 | 14.67B | 46.88% |
| Dec 31, 2002 | 9.99B | -51.34% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 60.63B |
| Haleon | 42.64B |
| Zoetis | 31.52B |
| United Therapeutics | 21.03B |
| Viatris | 19.46B |
| Neurocrine Biosciences | 16.10B |
| Elanco Animal Health | 12.20B |
| Dr. Reddy's Laboratories | 10.18B |